But researchers found that the virus is also a powerful risk factor for oropharyngeal cancer, which affects the tonsils, tongue and throat.

People whose immune systems had produced detectable antibodies against HPV molecules were 58 times more likely to have oropharyngeal cancer.

This is a real trend, and that is why there is concern of an epidemic given that fact that oropharyngeal cancer is increasing at an alarming rate.